Xu Cheng
Shenyang Pharmaceutical University(CN)Union Hospital(CN)Beijing University of Chinese Medicine(CN)Zunyi Medical University(CN)Liaoning University of Traditional Chinese Medicine(CN)Chinese PLA General Hospital(CN)Agricultural Genomics Institute at Shenzhen(CN)Hunan Academy of Agricultural Sciences(CN)Huazhong University of Science and Technology(CN)Hunan Agricultural University(CN)Yangzhou University(CN)
Publications by Year
Research Areas
Liver Disease Diagnosis and Treatment, COVID-19 Clinical Research Studies, Functional Brain Connectivity Studies, Peroxisome Proliferator-Activated Receptors, Long-Term Effects of COVID-19
Most-Cited Works
- → Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes(2020)1,643 cited
- → Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19(2020)1,181 cited
- → In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19(2020)498 cited
- → Longitudinal Association Between Markers of Liver Injury and Mortality in COVID‐19 in China(2020)446 cited
- → An ALOX12–12-HETE–GPR31 signaling axis is a key mediator of hepatic ischemia–reperfusion injury(2017)224 cited
- → One-Year Trajectory of Cognitive Changes in Older Survivors of COVID-19 in Wuhan, China(2022)215 cited